13-46895856-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2
The NM_000621.5(HTR2A):c.51C>T(p.Ser17=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00011 in 1,613,780 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.00064 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000055 ( 0 hom. )
Consequence
HTR2A
NM_000621.5 synonymous
NM_000621.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.65
Genes affected
HTR2A (HGNC:5293): (5-hydroxytryptamine receptor 2A) This gene encodes one of the receptors for serotonin, a neurotransmitter with many roles. Mutations in this gene are associated with susceptibility to schizophrenia and obsessive-compulsive disorder, and are also associated with response to the antidepressant citalopram in patients with major depressive disorder (MDD). MDD patients who also have a mutation in intron 2 of this gene show a significantly reduced response to citalopram as this antidepressant downregulates expression of this gene. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.35).
BP6
Variant 13-46895856-G-A is Benign according to our data. Variant chr13-46895856-G-A is described in ClinVar as [Benign]. Clinvar id is 731446.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.65 with no splicing effect.
BS2
High AC in GnomAd4 at 97 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HTR2A | NM_000621.5 | c.51C>T | p.Ser17= | synonymous_variant | 2/4 | ENST00000542664.4 | NP_000612.1 | |
HTR2A | NM_001378924.1 | c.51C>T | p.Ser17= | synonymous_variant | 2/4 | NP_001365853.1 | ||
HTR2A | NM_001165947.5 | c.-78+818C>T | intron_variant | NP_001159419.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HTR2A | ENST00000542664.4 | c.51C>T | p.Ser17= | synonymous_variant | 2/4 | 1 | NM_000621.5 | ENSP00000437737 | P1 | |
HTR2A | ENST00000543956.5 | c.-78+818C>T | intron_variant | 1 | ENSP00000441861 | |||||
HTR2A | ENST00000612998.1 | upstream_gene_variant | ENSP00000482708 |
Frequencies
GnomAD3 genomes AF: 0.000638 AC: 97AN: 152108Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
97
AN:
152108
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000163 AC: 41AN: 250990Hom.: 1 AF XY: 0.0000959 AC XY: 13AN XY: 135620
GnomAD3 exomes
AF:
AC:
41
AN:
250990
Hom.:
AF XY:
AC XY:
13
AN XY:
135620
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000547 AC: 80AN: 1461554Hom.: 0 Cov.: 33 AF XY: 0.0000426 AC XY: 31AN XY: 727046
GnomAD4 exome
AF:
AC:
80
AN:
1461554
Hom.:
Cov.:
33
AF XY:
AC XY:
31
AN XY:
727046
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000637 AC: 97AN: 152226Hom.: 0 Cov.: 32 AF XY: 0.000510 AC XY: 38AN XY: 74448
GnomAD4 genome
AF:
AC:
97
AN:
152226
Hom.:
Cov.:
32
AF XY:
AC XY:
38
AN XY:
74448
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 11, 2017 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at